In any given year, 15% of the US population has taken a benzodiazepine. About 6%, or 18 million people, have abused sedative hypnotic agents, another form of benzodiazepines. This alarming uptick in the use of benzodiazepines, combined with the number of patients we see on high doses of the drug, has led our research and development team to create the Benzodiazepine Taper Program.
This program is an extension of each patient’s inpatient medical detox plan of care. Our benzodiazepine protocol is specifically designed to help the patient complete their detoxification and begin their recovery in a tapered, safe environment, ensuring that the next steps towards their recovery are in place. The Benzodiazepine Taper Program works by slowly decreasing the patient’s consumption of the substance, allowing them to fully focus on improving their health and wellness.
In 2017, we started seeing more patients testing positive for fentanyl in our detox centers. Thanks to leading research, we can now effectively treat withdrawal symptoms prior to starting detox, giving fentanyl enough time to leave the patient’s system.
As a result, we now see patients with 42% fewer withdrawal symptoms during an AMI detox, and, on average, one fewer day spent in our care. No other detox center in the country is performing detox at this level with this much success.
Our proven protocol allows us to now provide detox to a patient at any level of methadone use.
While methadone detox can produce many side effects, the Gallus method of detox produces minimal symptoms.
Polysubstance addiction refers to a dependence or addiction to more than one substance at a time. We commonly see alcohol mixed with other substances. Other frequent combinations include benzodiazepines with opiates and methamphetamines mixed with other substances.
Our proprietary method of detox lowers withdrawal symptoms for polysubstance addiction and ensures patients are on the right track to recovery.
If you or someone you know is struggling with drugs or alcohol, call Gallus today and speak with our admissions team at